Gene therapy guards children against rare brain disease; GSK collaborates on new vaccines;

Conversations on Twitter :

 @FierceBiotech: Nuron Biotech bags $80M deal to back vaccines portfolio, PhIII multiple sclerosis drug work. Story | Follow @FierceBiotech

@JohnCFierce: Tredaptive failure likely to leave a mark at Merck, which spends more than $8B a year on R&D. This could trigger a reorg. News | Follow @JohnCFierce

@RyanMFierce: Biogen is teaming up on ALS research w/experts @ Yale Harvard & Columbia, committing $10M+, as its ALS rx is in P3. Release | Follow @RyanMFierce

> A group of children suffering from a rare and lethal genetic brain disorder have survived 7 to 10 years after being treated with a gene therapy that uses a benign virus to deliver its payload, Bloomberg reports. Investigators inserted the treatment after drilling holes in their skulls. Story

> GlaxoSmithKline ($GSK) has struck a deal to collaborate with GlycoVaxin AGon antibacterial conjugate vaccines. Story

> Sygnis Pharma says it will end an R&D project and cut 10 workers in Germany. Story

Pharma News

@FiercePharma: Judge thwarts Endo's effort to block non-tamper-resistant copies of Opana ER. FDA still might, tho. More | Follow @FiercePharma

> Sanofi settles Hyalgan kickback probe for $109M. Report

> CFO: No stock buybacks for Roche. Let's make a $7B deal instead. News

> Amgen whistleblower went undercover for the feds. Story

Medical Device News

 @FierceMedDev: DioGenix Series B funds crucial trial for MS Dx. Story | Follow @FierceMedDev

@MarkHFierce: A Novartis subsidiary is licensing Trovagene's find that a certain protein, found in urine, can indicate leukemia. News | Follow @MarkHFierce

 @DamianFierce: Privately held CardiacAssist is targeting the heart pump market after getting FDA OK for a pivotal trial. More | Follow @DamianFierce

> Covidien's catheter posts sterling 5-year results. Report

> Analyst report: Med Tech M&A and restructuring to surge in 2013. Article

Pharma Manufacturing News

> Hot for fish oil, BASF expands plant, pursues Pronova. News

> India API makers complain about cheap Chinese imports. Story

Vaccines News

 @AlisonBFierce: India is cruising along in the vaccines market. A WHO clearance will hoist the country's vaccine exports. More | Follow @AlisonBFierce

> U.N. contemplates ban on vaccine preservative. News

> FDA approves GSK's quadrivalent flu vaccine. Story

> Georgia State scientists investigate universal flu vaccine. More

And Finally… A new study highlights how a large number of primary care doctors struggle with treating obese patients. Release


Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.